-
The management of contralateral axillary sentinel lymph nodes detected by lymphoscintigraphy in a patient of breast cancer that had never undergone breast related medical treatment
Hisako Ono, Masahiko Tanabe, Kiyomi Kimura, Yumi Miyagi, Rie Horii, Futoshi Akiyama, Takuji Iwase, Shinji Ohno
Case Report: Clinical Investigation
-
The management of contralateral axillary sentinel lymph nodes detected by lymphoscintigraphy in a patient of breast cancer that had never undergone breast related medical treatment
Hisako Ono, Masahiko Tanabe, Kiyomi Kimura, Yumi Miyagi, Rie Horii, Futoshi Akiyama, Takuji Iwase, Shinji Ohno
Case Report: Clinical Investigation
-
The management of contralateral axillary sentinel lymph nodes detected by lymphoscintigraphy in a patient of breast cancer that had never undergone breast related medical treatment
Hisako Ono, Masahiko Tanabe, Kiyomi Kimura, Yumi Miyagi, Rie Horii, Futoshi Akiyama, Takuji Iwase, Shinji Ohno
Case Report: Clinical Investigation
-
The management of contralateral axillary sentinel lymph nodes detected by lymphoscintigraphy in a patient of breast cancer that had never undergone breast related medical treatment
Hisako Ono, Masahiko Tanabe, Kiyomi Kimura, Yumi Miyagi, Rie Horii, Futoshi Akiyama, Takuji Iwase, Shinji Ohno
Case Report: Clinical Investigation
-
The management of contralateral axillary sentinel lymph nodes detected by lymphoscintigraphy in a patient of breast cancer that had never undergone breast related medical treatment
Hisako Ono, Masahiko Tanabe, Kiyomi Kimura, Yumi Miyagi, Rie Horii, Futoshi Akiyama, Takuji Iwase, Shinji Ohno
Case Report: Clinical Investigation
-
The management of contralateral axillary sentinel lymph nodes detected by lymphoscintigraphy in a patient of breast cancer that had never undergone breast related medical treatment
Hisako Ono, Masahiko Tanabe, Kiyomi Kimura, Yumi Miyagi, Rie Horii, Futoshi Akiyama, Takuji Iwase, Shinji Ohno
Case Report: Clinical Investigation
-
The management of contralateral axillary sentinel lymph nodes detected by lymphoscintigraphy in a patient of breast cancer that had never undergone breast related medical treatment
Hisako Ono, Masahiko Tanabe, Kiyomi Kimura, Yumi Miyagi, Rie Horii, Futoshi Akiyama, Takuji Iwase, Shinji Ohno
Case Report: Clinical Investigation
-
The management of contralateral axillary sentinel lymph nodes detected by lymphoscintigraphy in a patient of breast cancer that had never undergone breast related medical treatment
Hisako Ono, Masahiko Tanabe, Kiyomi Kimura, Yumi Miyagi, Rie Horii, Futoshi Akiyama, Takuji Iwase, Shinji Ohno
Case Report: Clinical Investigation
-
Betamethasone valerate foam: a look at the clinical data
Avner Shemer, Nicole Sakka & Dov Tamarkin
Review: Clinical Trail Outcomes: Clinical Investigation
-
Betamethasone valerate foam: a look at the clinical data
Avner Shemer, Nicole Sakka & Dov Tamarkin
Review: Clinical Trail Outcomes: Clinical Investigation
-
Betamethasone valerate foam: a look at the clinical data
Avner Shemer, Nicole Sakka & Dov Tamarkin
Review: Clinical Trail Outcomes: Clinical Investigation
-
Betamethasone valerate foam: a look at the clinical data
Avner Shemer, Nicole Sakka & Dov Tamarkin
Review: Clinical Trail Outcomes: Clinical Investigation
-
Betamethasone valerate foam: a look at the clinical data
Avner Shemer, Nicole Sakka & Dov Tamarkin
Review: Clinical Trail Outcomes: Clinical Investigation
-
Betamethasone valerate foam: a look at the clinical data
Avner Shemer, Nicole Sakka & Dov Tamarkin
Review: Clinical Trail Outcomes: Clinical Investigation
-
Betamethasone valerate foam: a look at the clinical data
Avner Shemer, Nicole Sakka & Dov Tamarkin
Review: Clinical Trail Outcomes: Clinical Investigation
-
Betamethasone valerate foam: a look at the clinical data
Avner Shemer, Nicole Sakka & Dov Tamarkin
Review: Clinical Trail Outcomes: Clinical Investigation
-
Reassessment of the dysplastic nevus concept in the 21st century:a proposal for a two-tiered system of classification
Hebah Aboul-Fotouh, Lauren A Baker, Michelle Lucero Jackson ,Clay J Cockerell
Editorial: Clinical Investigation
-
Reassessment of the dysplastic nevus concept in the 21st century:a proposal for a two-tiered system of classification
Hebah Aboul-Fotouh, Lauren A Baker, Michelle Lucero Jackson ,Clay J Cockerell
Editorial: Clinical Investigation
-
Reassessment of the dysplastic nevus concept in the 21st century:a proposal for a two-tiered system of classification
Hebah Aboul-Fotouh, Lauren A Baker, Michelle Lucero Jackson ,Clay J Cockerell
Editorial: Clinical Investigation
-
Reassessment of the dysplastic nevus concept in the 21st century:a proposal for a two-tiered system of classification
Hebah Aboul-Fotouh, Lauren A Baker, Michelle Lucero Jackson ,Clay J Cockerell
Editorial: Clinical Investigation
-
Reassessment of the dysplastic nevus concept in the 21st century:a proposal for a two-tiered system of classification
Hebah Aboul-Fotouh, Lauren A Baker, Michelle Lucero Jackson ,Clay J Cockerell
Editorial: Clinical Investigation
-
Reassessment of the dysplastic nevus concept in the 21st century:a proposal for a two-tiered system of classification
Hebah Aboul-Fotouh, Lauren A Baker, Michelle Lucero Jackson ,Clay J Cockerell
Editorial: Clinical Investigation
-
Reassessment of the dysplastic nevus concept in the 21st century:a proposal for a two-tiered system of classification
Hebah Aboul-Fotouh, Lauren A Baker, Michelle Lucero Jackson ,Clay J Cockerell
Editorial: Clinical Investigation
-
Reassessment of the dysplastic nevus concept in the 21st century:a proposal for a two-tiered system of classification
Hebah Aboul-Fotouh, Lauren A Baker, Michelle Lucero Jackson ,Clay J Cockerell
Editorial: Clinical Investigation
-
Considerations in the design of clinical trials for relapsing multiple sclerosis
Richard Nicholas, Tim Friede
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for relapsing multiple sclerosis
Richard Nicholas, Tim Friede
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for relapsing multiple sclerosis
Richard Nicholas, Tim Friede
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for relapsing multiple sclerosis
Richard Nicholas, Tim Friede
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for relapsing multiple sclerosis
Richard Nicholas, Tim Friede
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for relapsing multiple sclerosis
Richard Nicholas, Tim Friede
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for relapsing multiple sclerosis
Richard Nicholas, Tim Friede
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for relapsing multiple sclerosis
Richard Nicholas, Tim Friede
Clinical Trail Methodology: Clinical Investigation
-
Design of clinical trials for biomarker research in oncology
Sumithra J Mandrekar, Daniel J Sargent
Clinical Trail Outcomes: Clinical Investigation
-
Design of clinical trials for biomarker research in oncology
Sumithra J Mandrekar, Daniel J Sargent
Clinical Trail Outcomes: Clinical Investigation
-
Design of clinical trials for biomarker research in oncology
Sumithra J Mandrekar, Daniel J Sargent
Clinical Trail Outcomes: Clinical Investigation
-
Design of clinical trials for biomarker research in oncology
Sumithra J Mandrekar, Daniel J Sargent
Clinical Trail Outcomes: Clinical Investigation
-
Design of clinical trials for biomarker research in oncology
Sumithra J Mandrekar, Daniel J Sargent
Clinical Trail Outcomes: Clinical Investigation
-
Design of clinical trials for biomarker research in oncology
Sumithra J Mandrekar, Daniel J Sargent
Clinical Trail Outcomes: Clinical Investigation
-
Design of clinical trials for biomarker research in oncology
Sumithra J Mandrekar, Daniel J Sargent
Clinical Trail Outcomes: Clinical Investigation
-
Design of clinical trials for biomarker research in oncology
Sumithra J Mandrekar, Daniel J Sargent
Clinical Trail Outcomes: Clinical Investigation